Stem Cell 3D Cluster Culture for Angiogenesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for inducing angiogenesis using stem cells are limited by low yields and inefficient differentiation of stem cells into vascular endothelial cells, with most reports suggesting that growth factors rather than stem cells themselves induce angiogenesis, and existing methods for differentiating adipose stem cells into vascular endothelial cells result in low proliferation and differentiation rates.

Innovation Solution

A method involving the culture of stem cells in a three-dimensional cell cluster by adhering them to a hydrophobic culture plate or one with immobilized growth factors, allowing the cells to detach and form clusters at high density, creating hypoxia that induces the production of angiogenic stimulators and differentiation into vascular cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If stem cells are individually transplanted or cultured in traditional two-dimensional monolayer, then the process is simple to operate, but the differentiation yield into vascular endothelial cells is low and proliferation rate is poor

Engineering Contradiction:
Improvedifferentiation yieldVSAvoidculture method complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent transitions from traditional two-dimensional monolayer culture to three-dimensional cell cluster culture. Stem cells are initially cultured on a culture plate surface to form a monolayer, then detached and re-cultured to form three-dimensional spherical clusters. This dimensional change significantly improves the differentiation yield into vascular endothelial cells and enhances cell proliferation rates, as the 3D structure better mimics in vivo conditions and promotes cell-cell interactions.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Productivity

If stem cells are cultured in three-dimensional cell cluster, then high-yield differentiation into vascular cells is achieved, but the culture process becomes more complex

Engineering Contradiction:
Improvedifferentiation yieldVSAvoidculture operation simplicity
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The patent employs a two-stage culture approach where stem cells are first pre-cultured on a culture plate surface to form a monolayer, achieving high cell density and uniform distribution. Then the cells are detached and re-cultured in suspension to form three-dimensional clusters. This preliminary action simplifies the overall process by preparing cells in an optimal state before the critical 3D cluster formation stage, making the complex 3D culture more manageable and reproducible.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If growth factors are used to induce angiogenesis, then angiogenic stimulation is achieved, but the cost is high and purification is difficult

Engineering Contradiction:
Improveangiogenesis inductionVSAvoidtherapeutic agent production
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent utilizes the endogenous ability of stem cells to secrete angiogenic growth factors such as VEGF, bFGF, and PDEGF. Rather than externally administering purified growth factors, the stem cells themselves serve as the source of these angiogenic stimuli. This self-service approach eliminates the need for expensive purification and administration of external growth factors, while maintaining reliable angiogenesis induction through the natural paracrine signaling of the transplanted stem cells.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-yield differentiation of stem cells into vascular endothelial cells, which can effectively form mature blood vessels in vivo when transplanted, providing a cell therapy agent for vascular diseases and tissue engineering.

Implementation Method 1

culturing stem cells by adhering them onto a culture plate with a surface having a hydrophobic property

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 2

the formed cell cluster creates hypoxia, thereby inducing the production of angiogenic stimulators

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS9644183B2Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
Publication Date: 2017.05.09 S-BIOMEDICS CO LTD
  • US9644183B2 patent drawing
  • US9644183B2 patent drawing
  • US9644183B2 patent drawing

AI summary

A method for differentiating stem cells into vascular cells, including adhering the stem cells to a culture plate with a surface having a hydrophobic property or on which a growth factor is immobilized, and culturing the cells. The cultured stem cells later detach from the culture plate as their density increases to form a three-dimensional cell cluster and differentiate into vascular cells. The cell cluster can be used as a cell therapy agent for angiogenesis.